These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 29095571)

  • 1. Generative Recurrent Networks for De Novo Drug Design.
    Gupta A; Müller AT; Huisman BJH; Fuchs JA; Schneider P; Schneider G
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29095571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generative machine learning for de novo drug discovery: A systematic review.
    Martinelli DD
    Comput Biol Med; 2022 Jun; 145():105403. PubMed ID: 35339849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Has Artificial Intelligence Impacted Drug Discovery?
    Patronov A; Papadopoulos K; Engkvist O
    Methods Mol Biol; 2022; 2390():153-176. PubMed ID: 34731468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Chemical Autoencoder Latent Space and Molecular
    Bjerrum EJ; Sattarov B
    Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30380783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?
    D'Souza S; Kv P; Balaji S
    Expert Opin Drug Discov; 2022 Oct; 17(10):1071-1079. PubMed ID: 36216812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generating and screening de novo compounds against given targets using ultrafast deep learning models as core components.
    Zhang H; Saravanan KM; Yang Y; Wei Y; Yi P; Zhang JZH
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35724626
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Grisoni F; Schneider G
    Chimia (Aarau); 2019 Dec; 73(12):1006-1011. PubMed ID: 31883552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De Novo Design of Bioactive Small Molecules by Artificial Intelligence.
    Merk D; Friedrich L; Grisoni F; Schneider G
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29319225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generative chemistry: drug discovery with deep learning generative models.
    Bian Y; Xie XQ
    J Mol Model; 2021 Feb; 27(3):71. PubMed ID: 33543405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graph-based generative models for de Novo drug design.
    Xia X; Hu J; Wang Y; Zhang L; Liu Z
    Drug Discov Today Technol; 2019 Dec; 32-33():45-53. PubMed ID: 33386094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory augmented recurrent neural networks for de-novo drug design.
    Suresh N; Chinnakonda Ashok Kumar N; Subramanian S; Srinivasa G
    PLoS One; 2022; 17(6):e0269461. PubMed ID: 35737661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Target to Drug: Generative Modeling for the Multimodal Structure-Based Ligand Design.
    Skalic M; Sabbadin D; Sattarov B; Sciabola S; De Fabritiis G
    Mol Pharm; 2019 Oct; 16(10):4282-4291. PubMed ID: 31437001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generative Deep Learning for Targeted Compound Design.
    Sousa T; Correia J; Pereira V; Rocha M
    J Chem Inf Model; 2021 Nov; 61(11):5343-5361. PubMed ID: 34699719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De Novo Peptide and Protein Design Using Generative Adversarial Networks: An Update.
    Lin E; Lin CH; Lane HY
    J Chem Inf Model; 2022 Feb; 62(4):761-774. PubMed ID: 35128926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial Intelligent Deep Learning Molecular Generative Modeling of Scaffold-Focused and Cannabinoid CB2 Target-Specific Small-Molecule Sublibraries.
    Bian Y; Xie XQ
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo Molecular Design with Chemical Language Models.
    Grisoni F; Schneider G
    Methods Mol Biol; 2022; 2390():207-232. PubMed ID: 34731471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faster and more diverse de novo molecular optimization with double-loop reinforcement learning using augmented SMILES.
    Bjerrum EJ; Margreitter C; Blaschke T; Kolarova S; de Castro RL
    J Comput Aided Mol Des; 2023 Aug; 37(8):373-394. PubMed ID: 37329395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in de Novo Drug Design: From Conventional to Machine Learning Methods.
    Mouchlis VD; Afantitis A; Serra A; Fratello M; Papadiamantis AG; Aidinis V; Lynch I; Greco D; Melagraki G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNMG: Deep molecular generative model by fusion of 3D information for de novo drug design.
    Song T; Ren Y; Wang S; Han P; Wang L; Li X; Rodriguez-Patón A
    Methods; 2023 Mar; 211():10-22. PubMed ID: 36764588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.